ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Decrease in Thalamic Volumes of Refractory Patients with Obsessive-Compulsive Disorder who Were Submitted to Gamma Ventral Capsulotomy (2015)
Costa, Douglas; Batistuzzo, Marcelo; Duran, Fabio; Greenberg, Benjamin; Canteras, Miguel; Shavitt, Roseli; Gentil, Andre; Miguel, Euripedes; Lopes, Antonio; Hoext, Marcelo
Source: Neuropsychopharmacology. Conference titles: Annual Meeting of the American College of Neuropsychopharmacology. Unidade: FM
Subjects: TRANSTORNO OBSESSIVO-COMPULSIVO (FISIOPATOLOGIA), SINAIS E SINTOMAS, PREVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Douglas et al. Decrease in Thalamic Volumes of Refractory Patients with Obsessive-Compulsive Disorder who Were Submitted to Gamma Ventral Capsulotomy. Neuropsychopharmacology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.nature.com/npp/journal/v40/n1s/pdf/npp2015327a.pdf. Acesso em: 04 nov. 2024. , 2015
APA
Costa, D., Batistuzzo, M., Duran, F., Greenberg, B., Canteras, M., Shavitt, R., et al. (2015). Decrease in Thalamic Volumes of Refractory Patients with Obsessive-Compulsive Disorder who Were Submitted to Gamma Ventral Capsulotomy. Neuropsychopharmacology. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.nature.com/npp/journal/v40/n1s/pdf/npp2015327a.pdf
NLM
Costa D, Batistuzzo M, Duran F, Greenberg B, Canteras M, Shavitt R, Gentil A, Miguel E, Lopes A, Hoext M. Decrease in Thalamic Volumes of Refractory Patients with Obsessive-Compulsive Disorder who Were Submitted to Gamma Ventral Capsulotomy [Internet]. Neuropsychopharmacology. 2015 ; 40 S453-S454.[citado 2024 nov. 04 ] Available from: http://www.nature.com/npp/journal/v40/n1s/pdf/npp2015327a.pdf
Vancouver
Costa D, Batistuzzo M, Duran F, Greenberg B, Canteras M, Shavitt R, Gentil A, Miguel E, Lopes A, Hoext M. Decrease in Thalamic Volumes of Refractory Patients with Obsessive-Compulsive Disorder who Were Submitted to Gamma Ventral Capsulotomy [Internet]. Neuropsychopharmacology. 2015 ; 40 S453-S454.[citado 2024 nov. 04 ] Available from: http://www.nature.com/npp/journal/v40/n1s/pdf/npp2015327a.pdf
Trabalho de evento-resumo periodico
Orbitofrontal thickness as a measure for treatment response classification in obsessive-compulsive disorder (2014)
Hoexter, Marcelo; Diniz, Juliana; Lopes, Antonio; Batistuzzo, Marcelo; Shavitt, Roseli; Dougherty, Darin; Duran, Fabio; Bressan, Rodrigo; Busatto, Geraldo; Miguel, Euripides; Sato, João
Source: Neuropsychopharmacology. Conference titles: American College of Neuropsychopharmacology (ACNP). Unidade: FM
Subjects: TRANSTORNO OBSESSIVO-COMPULSIVO (TERAPIA), BIOMARCADORES, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOEXTER, Marcelo et al. Orbitofrontal thickness as a measure for treatment response classification in obsessive-compulsive disorder. Neuropsychopharmacology. New York: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2014
APA
Hoexter, M., Diniz, J., Lopes, A., Batistuzzo, M., Shavitt, R., Dougherty, D., et al. (2014). Orbitofrontal thickness as a measure for treatment response classification in obsessive-compulsive disorder. Neuropsychopharmacology. New York: Faculdade de Medicina, Universidade de São Paulo.
NLM
Hoexter M, Diniz J, Lopes A, Batistuzzo M, Shavitt R, Dougherty D, Duran F, Bressan R, Busatto G, Miguel E, Sato J. Orbitofrontal thickness as a measure for treatment response classification in obsessive-compulsive disorder. Neuropsychopharmacology. 2014 ; 39( 51): S230-231.[citado 2024 nov. 04 ]
Vancouver
Hoexter M, Diniz J, Lopes A, Batistuzzo M, Shavitt R, Dougherty D, Duran F, Bressan R, Busatto G, Miguel E, Sato J. Orbitofrontal thickness as a measure for treatment response classification in obsessive-compulsive disorder. Neuropsychopharmacology. 2014 ; 39( 51): S230-231.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder: A review of emerging clinical evidence and considerations for optimal electrodes montage (2014)
Senço, Natasha; Huang, Yu; D'Urso, Giordano; Parra, Lucas; Bikson, Marom; Mantovani, Antonio; Shavitt, Roseli; Hoexter, Marcelo; Brunoni, Andre; Miguel, Euripides
Source: Neuropsychopharmacology. Conference titles: American College of Neuropsychopharmacology (ACNP). Unidades: RUSP, FM
Subjects: TRANSTORNO OBSESSIVO-COMPULSIVO (TERAPIA), TERAPIA POR ESTIMULAÇÃO ELÉTRICA, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SENÇO, Natasha et al. Transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder: A review of emerging clinical evidence and considerations for optimal electrodes montage. Neuropsychopharmacology. New York: , Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 2014
APA
Senço, N., Huang, Y., D'Urso, G., Parra, L., Bikson, M., Mantovani, A., et al. (2014). Transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder: A review of emerging clinical evidence and considerations for optimal electrodes montage. Neuropsychopharmacology. New York: , Universidade de São Paulo.
NLM
Senço N, Huang Y, D'Urso G, Parra L, Bikson M, Mantovani A, Shavitt R, Hoexter M, Brunoni A, Miguel E. Transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder: A review of emerging clinical evidence and considerations for optimal electrodes montage. Neuropsychopharmacology. 2014 ; 39( 51): S559.[citado 2024 nov. 04 ]
Vancouver
Senço N, Huang Y, D'Urso G, Parra L, Bikson M, Mantovani A, Shavitt R, Hoexter M, Brunoni A, Miguel E. Transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder: A review of emerging clinical evidence and considerations for optimal electrodes montage. Neuropsychopharmacology. 2014 ; 39( 51): S559.[citado 2024 nov. 04 ]
Artigo de periodico
Bcl-2 rs956572 Polymorphism is Associated with Increased Anterior Cingulate Cortical Glutamate in Euthymic Bipolar I Disorder (2013)
Soeiro-de-Souza, Márcio Gerhardt; Salvadore, Giacomo; Moreno, Ricardo Alberto; Otaduy, Maria Concepción Garcia; Chaim, Kalil T.; Gattaz, Wagner F.; Zarate Jr., Carlos A.; Machado-Vieira, Rodrigo
Source: Neuropsychopharmacology. Unidade: FM
Subjects: TRANSTORNO BIPOLAR, POLIMORFISMO, GLUTAMATOS, CÁLCIO, DEPRESSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOEIRO-DE-SOUZA, Márcio Gerhardt et al. Bcl-2 rs956572 Polymorphism is Associated with Increased Anterior Cingulate Cortical Glutamate in Euthymic Bipolar I Disorder. Neuropsychopharmacology, v. 38, n. 3, p. 468-475, 2013Tradução . . Disponível em: https://doi.org/10.1038/npp.2012.203. Acesso em: 04 nov. 2024.
APA
Soeiro-de-Souza, M. G., Salvadore, G., Moreno, R. A., Otaduy, M. C. G., Chaim, K. T., Gattaz, W. F., et al. (2013). Bcl-2 rs956572 Polymorphism is Associated with Increased Anterior Cingulate Cortical Glutamate in Euthymic Bipolar I Disorder. Neuropsychopharmacology, 38( 3), 468-475. doi:10.1038/npp.2012.203
NLM
Soeiro-de-Souza MG, Salvadore G, Moreno RA, Otaduy MCG, Chaim KT, Gattaz WF, Zarate Jr. CA, Machado-Vieira R. Bcl-2 rs956572 Polymorphism is Associated with Increased Anterior Cingulate Cortical Glutamate in Euthymic Bipolar I Disorder [Internet]. Neuropsychopharmacology. 2013 ; 38( 3): 468-475.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1038/npp.2012.203
Vancouver
Soeiro-de-Souza MG, Salvadore G, Moreno RA, Otaduy MCG, Chaim KT, Gattaz WF, Zarate Jr. CA, Machado-Vieira R. Bcl-2 rs956572 Polymorphism is Associated with Increased Anterior Cingulate Cortical Glutamate in Euthymic Bipolar I Disorder [Internet]. Neuropsychopharmacology. 2013 ; 38( 3): 468-475.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1038/npp.2012.203
Artigo de periodico
Gray Matter Volumes in Obsessive-Compulsive Disorder Before and After Fluoxetine or Cognitive-Behavior Therapy: A Randomized Clinical Trial (2012)
Hoexter, Marcelo Queiroz; Duran, Fábio Luis de Souza; D'Alcante, Carina Chaubet; Dougherty, Darin Dean; Shavitt, Antonio Carlos Lopes; Diniz, Juliana Belo; Deckersbach, Thilo; Batistuzzo, Marcelo Camargo; Bressan, Rodrigo Affonseca; Miguel, Euripedes Constantino; Busatto Filho, Geraldo
Source: Neuropsychopharmacology. Unidade: FM
Subjects: TRANSTORNO OBSESSIVO-COMPULSIVO, TERAPIA COGNITIVA, TERAPIA COMPORTAMENTAL, NEUROTRANSMISSORES (ANÁLISE), IMAGEM POR RESSONÂNCIA MAGNÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOEXTER, Marcelo Queiroz et al. Gray Matter Volumes in Obsessive-Compulsive Disorder Before and After Fluoxetine or Cognitive-Behavior Therapy: A Randomized Clinical Trial. Neuropsychopharmacology, v. 37, n. 3, p. 734-745, 2012Tradução . . Disponível em: https://doi.org/10.1038/npp.2011.250. Acesso em: 04 nov. 2024.
APA
Hoexter, M. Q., Duran, F. L. de S., D'Alcante, C. C., Dougherty, D. D., Shavitt, A. C. L., Diniz, J. B., et al. (2012). Gray Matter Volumes in Obsessive-Compulsive Disorder Before and After Fluoxetine or Cognitive-Behavior Therapy: A Randomized Clinical Trial. Neuropsychopharmacology, 37( 3), 734-745. doi:10.1038/npp.2011.250
NLM
Hoexter MQ, Duran FL de S, D'Alcante CC, Dougherty DD, Shavitt ACL, Diniz JB, Deckersbach T, Batistuzzo MC, Bressan RA, Miguel EC, Busatto Filho G. Gray Matter Volumes in Obsessive-Compulsive Disorder Before and After Fluoxetine or Cognitive-Behavior Therapy: A Randomized Clinical Trial [Internet]. Neuropsychopharmacology. 2012 ; 37( 3): 734-745.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1038/npp.2011.250
Vancouver
Hoexter MQ, Duran FL de S, D'Alcante CC, Dougherty DD, Shavitt ACL, Diniz JB, Deckersbach T, Batistuzzo MC, Bressan RA, Miguel EC, Busatto Filho G. Gray Matter Volumes in Obsessive-Compulsive Disorder Before and After Fluoxetine or Cognitive-Behavior Therapy: A Randomized Clinical Trial [Internet]. Neuropsychopharmacology. 2012 ; 37( 3): 734-745.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1038/npp.2011.250
Artigo de periodico
Acquisition of pavlovian fear conditioning using β-adrenoceptor activation of the dorsal premammillary nucleus as an unconditioned stimulus to mimic live predator-threat exposure (2011)
Pavesi, Eloisa; Canteras, Newton Sabino ; Carobrez, Antônio P.
Source: Neuropsychopharmacology. Unidade: ICB
Assunto: ANATOMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAVESI, Eloisa e CANTERAS, Newton Sabino e CAROBREZ, Antônio P. Acquisition of pavlovian fear conditioning using β-adrenoceptor activation of the dorsal premammillary nucleus as an unconditioned stimulus to mimic live predator-threat exposure. Neuropsychopharmacology, v. 36, n. 5, p. 926-939, 2011Tradução . . Disponível em: https://doi.org/10.1038/npp.2010.231. Acesso em: 04 nov. 2024.
APA
Pavesi, E., Canteras, N. S., & Carobrez, A. P. (2011). Acquisition of pavlovian fear conditioning using β-adrenoceptor activation of the dorsal premammillary nucleus as an unconditioned stimulus to mimic live predator-threat exposure. Neuropsychopharmacology, 36( 5), 926-939. doi:10.1038/npp.2010.231
NLM
Pavesi E, Canteras NS, Carobrez AP. Acquisition of pavlovian fear conditioning using β-adrenoceptor activation of the dorsal premammillary nucleus as an unconditioned stimulus to mimic live predator-threat exposure [Internet]. Neuropsychopharmacology. 2011 ; 36( 5): 926-939.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1038/npp.2010.231
Vancouver
Pavesi E, Canteras NS, Carobrez AP. Acquisition of pavlovian fear conditioning using β-adrenoceptor activation of the dorsal premammillary nucleus as an unconditioned stimulus to mimic live predator-threat exposure [Internet]. Neuropsychopharmacology. 2011 ; 36( 5): 926-939.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1038/npp.2010.231
Artigo de periodico
Effects of Cannabidiol (CBD) on regional cerebral blood flow (2004)
Crippa, José ALexandre de Souza; Zuardi, Antonio Waldo; Garrido, Griselda E. J.; Wichert-Ana, Lauro; Guarnieri, Ricardo; Ferrari, Lucas; Azevedo-Marques, Paulo M.; Hallak, Jaime Eduardo Cecílio; McGuire, Philip K.; Busatto Filho, Geraldo
Source: Neuropsychopharmacology. Unidades: FM, FMRP
Subjects: CANNABIS, ANSIEDADE, TOMOGRAFIA COMPUTADORIZADA POR EMISSÃO DE FÓTON ÚNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José ALexandre de Souza et al. Effects of Cannabidiol (CBD) on regional cerebral blood flow. Neuropsychopharmacology, v. 29, p. 417-426, 2004Tradução . . Acesso em: 04 nov. 2024.
APA
Crippa, J. A. L. de S., Zuardi, A. W., Garrido, G. E. J., Wichert-Ana, L., Guarnieri, R., Ferrari, L., et al. (2004). Effects of Cannabidiol (CBD) on regional cerebral blood flow. Neuropsychopharmacology, 29, 417-426.
NLM
Crippa JAL de S, Zuardi AW, Garrido GEJ, Wichert-Ana L, Guarnieri R, Ferrari L, Azevedo-Marques PM, Hallak JEC, McGuire PK, Busatto Filho G. Effects of Cannabidiol (CBD) on regional cerebral blood flow. Neuropsychopharmacology. 2004 ; 29 417-426.[citado 2024 nov. 04 ]
Vancouver
Crippa JAL de S, Zuardi AW, Garrido GEJ, Wichert-Ana L, Guarnieri R, Ferrari L, Azevedo-Marques PM, Hallak JEC, McGuire PK, Busatto Filho G. Effects of Cannabidiol (CBD) on regional cerebral blood flow. Neuropsychopharmacology. 2004 ; 29 417-426.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Are benzodiazepines really harmless? (1994)
Gorenstein, Clarice ; Bernik, M A; Pompeia, S; Marcourakis, Tania
Source: Neuropsychopharmacology. Conference titles: Collegium Internationale Neuropsychopharmacologicum Congress. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GORENSTEIN, Clarice et al. Are benzodiazepines really harmless?. Neuropsychopharmacology. [S.l.]: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 1994
APA
Gorenstein, C., Bernik, M. A., Pompeia, S., & Marcourakis, T. (1994). Are benzodiazepines really harmless? Neuropsychopharmacology. Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Gorenstein C, Bernik MA, Pompeia S, Marcourakis T. Are benzodiazepines really harmless? Neuropsychopharmacology. 1994 ;10( 38 pt.2): 26s.[citado 2024 nov. 04 ]
Vancouver
Gorenstein C, Bernik MA, Pompeia S, Marcourakis T. Are benzodiazepines really harmless? Neuropsychopharmacology. 1994 ;10( 38 pt.2): 26s.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Clomipramine double-blind discontinuation in panic disorder patients (1994)
Lotufo Neto, Francisco; Gentil, V; Bernik, M A; Ramos, R; Cordas, T A; Gorenstein, Clarice ; Melo, M.; Andrade, L
Source: Neuropsychopharmacology. Conference titles: Collegium Internationale Neuropsychopharmacologicum Congress. Unidades: FM, ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO NETO, Francisco et al. Clomipramine double-blind discontinuation in panic disorder patients. Neuropsychopharmacology. [S.l.]: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 1994
APA
Lotufo Neto, F., Gentil, V., Bernik, M. A., Ramos, R., Cordas, T. A., Gorenstein, C., et al. (1994). Clomipramine double-blind discontinuation in panic disorder patients. Neuropsychopharmacology. Faculdade de Medicina, Universidade de São Paulo.
NLM
Lotufo Neto F, Gentil V, Bernik MA, Ramos R, Cordas TA, Gorenstein C, Melo M, Andrade L. Clomipramine double-blind discontinuation in panic disorder patients. Neuropsychopharmacology. 1994 ;10( 38 pt.2): 11s.[citado 2024 nov. 04 ]
Vancouver
Lotufo Neto F, Gentil V, Bernik MA, Ramos R, Cordas TA, Gorenstein C, Melo M, Andrade L. Clomipramine double-blind discontinuation in panic disorder patients. Neuropsychopharmacology. 1994 ;10( 38 pt.2): 11s.[citado 2024 nov. 04 ]
Trabalho de evento-resumo periodico
Lack of tolerance to benzodiazepine memory effects after long-term use (1994)
Gorenstein, Clarice ; Bernik, M A; Pompeia, S; Marcourakis, Tania
Source: Neuropsychopharmacology. Conference titles: Collegium Internationale Neuropsychopharmacologicum Congress. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GORENSTEIN, Clarice et al. Lack of tolerance to benzodiazepine memory effects after long-term use. Neuropsychopharmacology. [S.l.]: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 04 nov. 2024. , 1994
APA
Gorenstein, C., Bernik, M. A., Pompeia, S., & Marcourakis, T. (1994). Lack of tolerance to benzodiazepine memory effects after long-term use. Neuropsychopharmacology. Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Gorenstein C, Bernik MA, Pompeia S, Marcourakis T. Lack of tolerance to benzodiazepine memory effects after long-term use. Neuropsychopharmacology. 1994 ;10( 38 pt.2): 49s.[citado 2024 nov. 04 ]
Vancouver
Gorenstein C, Bernik MA, Pompeia S, Marcourakis T. Lack of tolerance to benzodiazepine memory effects after long-term use. Neuropsychopharmacology. 1994 ;10( 38 pt.2): 49s.[citado 2024 nov. 04 ]
Artigo de periodico
Repeated amphetamine and fencamfamine: sensitization and reciprocal cross-sensitization (1990)
Aizenstein, Moacyr Luiz; Segal, D D; Kuczenski, R
Source: Neuropsychopharmacology. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AIZENSTEIN, Moacyr Luiz e SEGAL, D D e KUCZENSKI, R. Repeated amphetamine and fencamfamine: sensitization and reciprocal cross-sensitization. Neuropsychopharmacology, v. 3 , n. 4 , p. 283-90, 1990Tradução . . Acesso em: 04 nov. 2024.
APA
Aizenstein, M. L., Segal, D. D., & Kuczenski, R. (1990). Repeated amphetamine and fencamfamine: sensitization and reciprocal cross-sensitization. Neuropsychopharmacology, 3 ( 4 ), 283-90.
NLM
Aizenstein ML, Segal DD, Kuczenski R. Repeated amphetamine and fencamfamine: sensitization and reciprocal cross-sensitization. Neuropsychopharmacology. 1990 ;3 ( 4 ): 283-90.[citado 2024 nov. 04 ]
Vancouver
Aizenstein ML, Segal DD, Kuczenski R. Repeated amphetamine and fencamfamine: sensitization and reciprocal cross-sensitization. Neuropsychopharmacology. 1990 ;3 ( 4 ): 283-90.[citado 2024 nov. 04 ]

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Indexado em